Home  »  Industry   »  The clock is ticking: InMed Pharmaceuticals Inc. (...

The clock is ticking: InMed Pharmaceuticals Inc. (INM)

For the readers interested in the stock health of InMed Pharmaceuticals Inc. (INM). It is currently valued at $2.12. When the transactions were called off in the previous session, Stock hit the highs of $2.25, after setting-off with the price of $1.87. Company’s stock value dipped to $1.87 during the trading on the day. When the trading was stopped its value was $1.79.Recently in News on January 10, 2023, InMed Provides Business Update and Milestones for 2023. Complete Phase 2 clinical trial enrollment in Epidermolysis Bullosa in 1Q 2023. You can read further details here

InMed Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.03 on 01/04/23, with the lowest value was $1.58 for the same time period, recorded on 01/09/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


InMed Pharmaceuticals Inc. (INM) full year performance was -93.43%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, InMed Pharmaceuticals Inc. shares are logging -94.03% during the 52-week period from high price, and 72.36% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.23 and $35.50.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 887140 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the InMed Pharmaceuticals Inc. (INM) recorded performance in the market was 4.95%, having the revenues showcasing -55.27% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.91M, as it employees total of 13 workers.

Specialists analysis on InMed Pharmaceuticals Inc. (INM)

During the last month, 0 analysts gave the InMed Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.34, with a change in the price was noted -4.38. In a similar fashion, InMed Pharmaceuticals Inc. posted a movement of -67.40% for the period of last 100 days, recording 1,313,073 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for INM is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Trends and Technical analysis: InMed Pharmaceuticals Inc. (INM)

Raw Stochastic average of InMed Pharmaceuticals Inc. in the period of last 50 days is set at 25.28%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 49.44%. In the last 20 days, the company’s Stochastic %K was 38.89% and its Stochastic %D was recorded 38.15%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 4.95%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -79.57%, alongside a downfall of -93.43% for the period of the last 12 months. The shares increased approximately by 2.42% in the 7-day charts and went down by 30.06% in the period of the last 30 days. Common stock shares were lifted by -55.27% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts